Recce Pharmaceuticals Ltd.ASX: RCE

Safety Committee Approves Expansion of Ph I/II DFI Trial

Feb 26, 2024 at 3:58 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment